Seeing HIV in positive light boosts patients' mental health

November 01, 2003

Seeing HIV in a more positive light -- as a challenge rather than a threat, for instance -- is associated with greater psychological well-being and lower levels of depression among patients, new research suggests.

Other factors, like social support and the ability to cope with problems, also contribute to an HIV patient's overall mental health, say Eugene W. Farber, Ph.D., of Emory University School of Medicine and colleagues.

But a patient's beliefs about the disease seem to affect psychological well-being above and beyond these other factors, the researchers conclude.

Patients may find it easier to cope with their disease if they see it as an "opportunity for personal growth" or can attach some other positive meaning to it, the researchers say. Their findings are published in the November issue of Psychosomatics.

"Psychotherapists can help their patients explore the personal significance and effects of HIV/AIDS and encourage ... realities that allow for pursuit of realistic options and choices within the acknowledged limits imposed by the disease," Farber says.

Patients' perceptions of their disease might also affect how well they stick to a medication schedule or avoid risky behaviors related to HIV infection, they add.

Farber and colleagues surveyed 203 mostly low-income people with HIV who were being treated at an urban outpatient clinic. The patients were asked about their strategies for coping with health difficulties, their general psychological well-being, their feelings about their illness and any support they received from others.

More than 73 percent of the patients were clinically depressed, which may "reflect the considerable emotional burden that presumably is associated with the simultaneous challenges of living with HIV/AIDS and managing the psychosocial stresses associated with poverty," the researchers say.
-end-
The study was supported by the Emory Medical Care Foundation.

FOR MORE INFORMATION
Health Behavior News Service: 202-387-2829 or www.hbns.org.
Interviews: Contact Eugene Farber at 404-616-6862 or efarber@emory.edu.
Psychosomatics: Contact Tom Wise, M.D., at 703-698-3626.

BY BECKY HAM, SCIENCE WRITER
HEALTH BEHAVIOR NEWS SERVICE

Center for Advancing Health

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.